NL-OMON36747已完成不适用
A ONE-WAY DRUG DRUG INTERACTION STUDY TO ASSESS THE EFFECT OF EFAVIRENZ ON THE PHARMACOKINETICS, SAFETY AND TOLERABILITY OF BMS-790052 IN HEALTHY SUBJECTS - BMS-790052/efavirenz drug-drug interaction study
Bristol-Myers Squibb0 个研究点目标入组 17 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 17
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Age: 18-49 years, inclusive
- •BMI: 18.0 - 32.0 kg/m2, inclusive
- •Females should be post menopausal or surgically sterile
排除标准
- •Suffering from: hepatitis B, hepatitis C, cancer or HIV/AIDS. In case of participation in another drug study within 90 days before the start of this study or being a blood donor within 90 days from the start of the study or in case of donating more than 1 liter of blood (men) or more than 1.5 liter of blood (women) in the 10 months prior the start of this study.
研究者
相似试验
已完成
不适用
A One-Way Drug-Drug Interaction Study to Assess the Effect of Ritonavir-boosted Atazanavir on the Pharmacokinetics, Safety and Tolerability of BMS-790052 in Healthy Subjectsviral liver inflammation10047438Hepatitis CNL-OMON36726Bristol-Myers Squibb14
尚未招募
1 期
A Phase 1 Drug-Drug Interaction Study to Assess the Interaction Potential of NB-4746 on CYP1A2 and CYP3A4 Substrates in Healthy VolunteersACTRN12624001072505ura Bio18
尚未招募
不适用
A phase 1 study to evaluate drug-drug interactions of Bojungikgitang with Clopidogrel, Atorvastatin, and Fimasartan/Amlodipine in healthy adult volunteersKCT0007296Kyunghee University-industry Cooperation Foundation42
已完成
不适用
A Drug-Drug Interaction, Safety and Efficacy Study With JNJ-56021927 (ARN-509) and Abiraterone Acetate in Subjects With Metastatic Castration-Resistant Prostate Cancer10036958prostate cancerNL-OMON44408Johnson & Johnson Pharmaceutical10
进行中（未招募）
Unknown
Drug interaction study with thyroid hormone and zinc preparation in healthy volunteersNutritional, Metabolic, EndocrineHypothyroidismISRCTN73459064niversity Hospital of Zurich15